ArticleFrontiers in pharmacology2022

Cyclovirobuxine D Ameliorates Experimental Diabetic Cardiomyopathy by Inhibiting Cardiomyocyte Pyroptosis

Ge Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.